Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: GRYPHON BIO INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2022-09-26 to 2024-09-25
Current total value of award: $749437
Description: NEW RESEARCH AND DEVELOPMENT CONTRACT AWARD FOR THE FEASIBILITY STUDY OF A SINGLE PLATFORM SOLUTION FOR BLOOD TESTING OF TRAUMATIC BRAIN INJURY BIOMARKERS FOR THE CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAM OFFICE